Combined local and systemic bleomycin administration in electrochemotherapy to reduce the number of treatment sessions
Maglietti Felipe, Tellado Matias, Olaiz Nahuel and 2 more
Radiology and Oncology · 2016
doi:10.1515/raon-2016-0015 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Electrochemotherapy (ECT), a medical treatment widely used in human patients for tumor treatment, increases bleomycin toxicity by 1000 fold in the treated area with an objective response rate of around 80%. Despite its high response rate, there are still 20% of cases in which the patients are not responding. This could be ascribed to the fact that bleomycin, when administered systemically, is not reaching the whole tumor mass properly because of the characteristics of tumor vascularization, in which case local administration could cover areas that are unreachable by systemic administration.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.